Research

A team at KIT has developed a solution that significantly improves novel biosensors for medical use and enables faster diagnosis of infectious diseases Rapid, straightforward and, at the same time, accurate diagnosis of highly contagious pathogens such as the SARS-CoV-2 virus, which caused the coronavirus pandemic, is crucial to curbing the spread of disease. This […]

Basel, Switzerland / Martinsried, Germany – 28 July, 2026 Celonic AG, a Swiss-based biologics Contract Development and Manufacturing Organization (CDMO), and Leukocare AG, a leading provider of drug product development services, today announced a collaboration to support biopharmaceutical companies developing increasingly complex biologics. The collaboration brings together Celonic’s expertise in cell line development, drug substance […]

Every company in the bioRN network has a story to tell. More importantly, every company has knowledge that can help others move faster, avoid mistakes and spark new collaborations. That is the idea behind bioRN’s Member2Member series. Instead of traditional company presentations, Member2Member opens the doors to our member organisations and puts their expertise centre […]

How can Europe strengthen its global competitiveness in biotechnology? Heidelberg, July 7th: This question was at the heart of a high-level roundtable hosted by the bioRN Life Science Cluster with Member of the European Parliament Hildegard Bentele. Representatives from Ascendis Pharma, BD, PROGEN, Novaliq, BASF Agricultural Solutions, PEPperPRINT, Evotec and Isenbruck Bösl Hörschler joined the […]

Heidelberg, Juni 2026 – Mit dem Final Event von GeneNovate® am 25. Juni in der Münchner Residenz endet die dritte Runde des bundesweiten Entrepreneurship-Programms der Nationalen Strategie für gen- und zellbasierte Therapien (Nationale Strategie GCT). Im Rahmen der Abschlussveranstaltung präsentierten Wissenschaftlerinnen und Wissenschaftler aus ganz Deutschland ihre innovativen Geschäftsideen mit Potenzial für zukünftige Gesundheitslösungen und […]

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

Wie kann aus wissenschaftlicher Forschung eine konkrete medizinische Therapie entstehen? Im Maschinenraum der Life Sciences leistet bioRN Life Science Cluster genau das: Unter anderem beim Thema Frauengesundheit Heidelberg, 30 April 2026: Frauen sterben früher und werden oft schlechter therapiert. Der Grund dafür: Die medizinische Forschung und Entwicklung waren lange Zeit überwiegend auf männliche Populationen ausgerichtet. […]

On the occasion of German Biotech Days (DBT) 2026 in Leipzig, the Working Group of the German BioRegions once again presented its renowned Innovation Award on 21 April 2026. For the past 19 years, the award has honored innovative biotechnological ideas that have been patented or filed for patent protection and show strong potential for […]

Stärkung der Biotech-Region Neckar-Rhein-Main Die Städte Heidelberg und Mainz wollen künftig eng zusammenarbeiten: Ihr Ziel ist es, die Region Neckar–Rhein–Main als internationale Innovations- und Biotech-Region weiterzuentwickeln. Dazu haben der Heidelberger Oberbürgermeister Eckart Würzner und der Mainzer Oberbürgermeister Nino Haase am Freitag, 24. April 2026, im Heidelberger Rathaus ein Memorandum of Understanding (MoU) unterzeichnet. An der […]